Intensively timed combination chemotherapy for the induction of adult patients with acute myeloid leukemia
Author:
Publisher
Wiley
Subject
Cancer Research,Oncology
Link
http://onlinelibrary.wiley.com/wol1/doi/10.1002/cncr.25516/fullpdf
Reference20 articles.
1. Timed sequential therapy of human leukemia based upon the response of leukemic cells to humoral growth factors;Burke;Cancer Res.,1977
2. In vivo cell growth and pharmacologic determinants of clinical response in acute myelogenous leukemia;Karp;Blood.,1989
3. Timed-sequential induction therapy improves postremission outcome in acute myeloid leukemia: a report from the Children's Cancer Group;Woods;Blood.,1996
4. Randomized comparison of double induction and timed-sequential induction to a “3 + 7” induction in adults with AML: long-term analysis of the Acute Leukemia French Association (ALFA) 9000 study;Castaigne;Blood.,2004
5. Timed sequential induction chemotherapy and risk-adapted postremission therapy for acute myelogenous leukemia;Kalaycio;Am J Hematol.,2008
Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Characteristics and outcomes of children, adolescent, and young adult patients with myelodysplastic neoplasms: A single-center retrospective analysis;Leukemia Research;2024-09
2. Recent Treatment Advances and the Role of Nanotechnology, Combination Products, and Immunotherapy in Changing the Therapeutic Landscape of Acute Myeloid Leukemia;Pharmaceutical Research;2019-06-24
3. Leukemic stem cell signatures identify novel therapeutics targeting acute myeloid leukemia;Blood Cancer Journal;2018-06
4. Timed sequential therapy for acute myelogenous leukemia: Results of a retrospective study of 301 patients and review of the literature;Leukemia Research;2017-10
5. Randomized multicenter phase II study of flavopiridol (alvocidib), cytarabine, and mitoxantrone (FLAM) versus cytarabine/daunorubicin (7+3) in newly diagnosed acute myeloid leukemia;Haematologica;2015-05-28
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3